BlackRock Advisors’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $1.1M | Buy |
10,145
+676
| +7% | +$73.4K | ﹤0.01% | 1760 |
|
|
2016
Q3 | $1.56M | Buy |
9,469
+264
| +3% | +$43.5K | ﹤0.01% | 1541 |
|
|
2016
Q2 | $1.31M | Buy |
9,205
+1,187
| +15% | +$169K | ﹤0.01% | 1616 |
|
|
2016
Q1 | $1.03M | Sell |
8,018
-117,256
| -94% | -$15.1M | ﹤0.01% | 1687 |
|
|
2015
Q4 | $18.7M | Buy |
125,274
+6,461
| +5% | +$965K | 0.02% | 558 |
|
|
2015
Q3 | $19.7M | Sell |
118,813
-12,360
| -9% | -$2.05M | 0.02% | 524 |
|
|
2015
Q2 | $31.7M | Buy |
131,173
+10,068
| +8% | +$2.43M | 0.03% | 399 |
|
|
2015
Q1 | $34.2M | Buy |
121,105
+118,978
| +5,594% | +$33.6M | 0.04% | 396 |
|
|
2014
Q4 | $332K | Hold |
2,127
| – | – | ﹤0.01% | 2269 |
|
|
2014
Q3 | $503K | Buy |
2,127
+236
| +12% | +$55.8K | ﹤0.01% | 1943 |
|
|
2014
Q2 | $447K | Sell |
1,891
-9,188
| -83% | -$2.17M | ﹤0.01% | 2057 |
|
|
2014
Q1 | $3.65M | Buy |
11,079
+7,523
| +212% | +$2.48M | ﹤0.01% | 1021 |
|
|
2013
Q4 | $243K | Buy |
3,556
+267
| +8% | +$18.2K | ﹤0.01% | 2524 |
|
|
2013
Q3 | $227K | Buy |
3,289
+447
| +16% | +$30.9K | ﹤0.01% | 2457 |
|
|
2013
Q2 | $127K | Buy |
+2,842
| New | +$127K | ﹤0.01% | 2739 |
|